Walgreens remains focused on clinical trials despite CVS exit

Walgreens is doubling down on clinical trials after competitor CVS Health said it would be exiting that market by the end of 2024, Yahoo Finance reported.

Advertisement

Retailers began launching research institutes during the pandemic to get access to more diverse study participants. However, CVS said May 15 it would be winding down its clinical trial business to focus on its “long-term strategic priorities.”

“We are full steam ahead as we continue to support many of our manufacturers that have come into the ecosystem since June,” Ramita Tandon, chief clinical trials officer at Walgreens, told Yahoo Finance in the May 15 story. “We’re very focused on what we’re doing at Walgreens because it’s part of the broader healthcare mission and journey that we’re on.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Disruptors

  • OpenAI signed its first international hospital partnership with Ramat Gan, Israel-based Sheba Medical Center. The deal, according to a July…

  • Amazon is hiring software and applied-science leaders, AI engineers and a healthcare cybersecurity specialist — the kinds of roles hospital…

Advertisement

Comments are closed.